well health technologies - WHTCF

WHTCF

Close Chg Chg %
3.68 0.06 1.50%

Closed Market

3.73

+0.06 (1.50%)

Volume: 9.90K

Last Updated:

Nov 21, 2024, 1:35 PM EDT

Company Overview: well health technologies - WHTCF

WHTCF Key Data

Open

$3.76

Day Range

3.72 - 3.76

52 Week Range

2.45 - 4.69

Market Cap

$916.19M

Shares Outstanding

248.96M

Public Float

192.11M

Beta

1.33

Rev. Per Employee

N/A

P/E Ratio

16.44

EPS

$0.22

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

37.33K

 

WHTCF Performance

1 Week
 
5.60%
 
1 Month
 
7.30%
 
3 Months
 
4.40%
 
1 Year
 
30.30%
 
5 Years
 
242.59%
 

WHTCF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About well health technologies - WHTCF

WELL Health Technologies Corp. operates as digital healthcare company, which engages in owning and operating a portfolio of primary healthcare facilities. Its virtual services includes telehealth, electronic medical record, patien portal, ePharmacy, billing and RCM, cybersecurity, and digital apps.. The company was founded by Hamed Shahbazi on November 23, 2010 and is headquartered in Vancouver, Canada.

WHTCF At a Glance

WELL Health Technologies Corp.
375 Water Street
Vancouver, British Columbia V6B 5C6
Phone 1-604-628-7266 Revenue 574.99M
Industry Medical/Nursing Services Net Income 60.75K
Sector Health Services 2023 Sales Growth 31.524%
Fiscal Year-end 12 / 2024 Employees N/A
View SEC Filings

WHTCF Valuation

P/E Current 15.993
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 9,732.55
Price to Sales Ratio 1.201
Price to Book Ratio 1.211
Price to Cash Flow Ratio 14.894
Enterprise Value to EBITDA 13.785
Enterprise Value to Sales 1.81
Total Debt to Enterprise Value 0.311

WHTCF Efficiency

Revenue/Employee N/A
Income Per Employee N/A
Receivables Turnover 6.879
Total Asset Turnover 0.563

WHTCF Liquidity

Current Ratio 1.153
Quick Ratio 1.146
Cash Ratio 0.284

WHTCF Profitability

Gross Margin 40.139
Operating Margin 5.297
Pretax Margin 2.561
Net Margin 0.011
Return on Assets 0.006
Return on Equity 0.011
Return on Total Capital 0.007
Return on Invested Capital 0.007

WHTCF Capital Structure

Total Debt to Total Equity 55.53
Total Debt to Total Capital 35.704
Total Debt to Total Assets 30.248
Long-Term Debt to Equity 47.587
Long-Term Debt to Total Capital 30.596
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Well Health Technologies - WHTCF

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
37.46M 241.14M 437.17M 574.99M
Sales Growth
+51.48% +543.79% +81.30% +31.52%
Cost of Goods Sold (COGS) incl D&A
24.82M 149.03M 246.61M 344.19M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
3.18M 30.48M 42.40M 45.02M
Depreciation
1.60M 6.08M 9.51M 11.16M
Amortization of Intangibles
1.58M 24.41M 32.89M 33.86M
COGS Growth
+37.38% +500.37% +65.47% +39.57%
Gross Income
12.63M 92.11M 190.57M 230.79M
Gross Income Growth
+89.75% +629.09% +106.89% +21.11%
Gross Profit Margin
+33.73% +38.20% +43.59% +40.14%
2020 2021 2022 2023 5-year trend
SG&A Expense
17.99M 98.52M 170.23M 200.34M
Research & Development
- - - -
-
Other SG&A
17.99M 98.52M 170.23M 200.34M
SGA Growth
+67.74% +447.57% +72.78% +17.69%
Other Operating Expense
- - - -
-
Unusual Expense
(1.25M) 4.06M (10.41M) (10.79M)
EBIT after Unusual Expense
(4.11M) (10.47M) 30.75M 41.25M
Non Operating Income/Expense
233.95K (2.11M) 578.41K (2.57M)
Non-Operating Interest Income
338.76K 442.68K 498.52K 565.32K
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
1.34M 7.17M 17.56M 23.95M
Interest Expense Growth
+35.61% +437.18% +144.86% +36.35%
Gross Interest Expense
1.34M 7.17M 17.56M 23.95M
Interest Capitalized
- - - -
-
Pretax Income
(5.21M) (19.75M) 13.77M 14.73M
Pretax Income Growth
+10.92% -279.24% +169.69% +6.97%
Pretax Margin
-13.91% -8.19% +3.15% +2.56%
Income Tax
(3.25M) 4.72M (883.36K) 2.12M
Income Tax - Current - Domestic
- 377.19K 2.21M 9.40M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- (3.63M) (3.10M) (7.28M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(2.39M) (24.64M) 14.34M 12.33M
Minority Interest Expense
354.74K 10.28M 13.29M 12.27M
Net Income
(2.75M) (34.93M) 1.05M 60.75K
Net Income Growth
+53.36% -1,170.74% +103.01% -94.22%
Net Margin Growth
-7.34% -14.48% +0.24% +0.01%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(2.75M) (34.93M) 1.05M 60.75K
Preferred Dividends
- - - -
-
Net Income Available to Common
(2.75M) (34.93M) 1.05M 60.75K
EPS (Basic)
-0.0205 -0.1829 0.0048 0.0003
EPS (Basic) Growth
+66.28% -792.20% +102.62% -93.75%
Basic Shares Outstanding
133.91M 190.90M 220.69M 236.54M
EPS (Diluted)
-0.0205 -0.1829 0.0048 0.0003
EPS (Diluted) Growth
+66.28% -792.20% +102.62% -93.75%
Diluted Shares Outstanding
133.91M 190.90M 220.69M 236.54M
EBITDA
(2.18M) 24.07M 62.74M 75.48M
EBITDA Growth
+10.99% +1,206.05% +160.70% +20.31%
EBITDA Margin
-5.81% +9.98% +14.35% +13.13%

Well Health Technologies in the News